Home » Topics » Regulatory

Regulatory
RSS

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Shire's once-daily Adderall XR launched in U.S. for treatment of ADHD

Oct. 30, 2001

First regulatory approval obtained for Viread

Oct. 30, 2001

Successful completion of oxymorphone pain management clinical trial

Oct. 30, 2001

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...